Compounds that modulate processes associated with IgE production
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 16, 2008
Grant Date -
Sep 11, 2003
app pub date -
Mar 15, 2002
filing date -
Mar 8, 2002
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL-4 induced processes associated therewith, methods and kits for identifying such compounds that utilize a retinoid X receptor as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully